Business Wire

CD&R/PERMIRA

24.7.2024 07:13:26 CEST | Business Wire | Press release

Share
CD&R and Everest UK HoldCo Limited, an Entity Controlled by the Permira Funds, to Form a Consortium to Acquire a Majority Stake in Exclusive Networks and File a Simplified Mandatory Tender Offer

CD&R and Everest UK HoldCo Limited, an entity controlled by the Permira funds and the majority shareholder of Exclusive Networks, are pleased to announce that they intend to form a consortium with a view to acquire (directly or indirectly, by way of sales and contributions), through a dedicated entity (“BidCo”) the shares of Exclusive Networks held by Everest UK HoldCo Limited and Olivier Breittmayer, representing 66.7% of the share capital and 66.7% of the theoretical voting rights of Exclusive Networks1, at a price of €18.96 per share following payment of the exceptional distribution of €5.29 per share (the “Acquisitions”).

Following the payment of the exceptional distribution of reserves and premia to the shareholders and the closing of the Acquisitions thereafter, BidCo, which will be jointly controlled by CD&R and Everest UK HoldCo Limited, will launch a simplified mandatory tender offer on the Exclusive Networks shares not acquired as part of the Acquisitions, other than the shares held in treasury by the Company, at a price of €18.96 per share (ex-distribution of €5.29 per share attached) (the “Offer”, and together with the Acquisitions the “Proposed Transaction”). BidCo will subsequently request the implementation of a squeeze-out if the legal conditions are met at the end of the Offer.

This price of €24.25 per Exclusive Networks share (with right to exceptional distribution attached) would reflect a 34.4% premium to the undisturbed share price of €18.04 as of 13 March 2024 (being the date prior to initial market rumours) and a premium of 31.3%, 31.9% and 34.1%, respectively, on the volume-weighted 60, 120 and 180 day average share prices2 prior to that date, as well as a premium of 15.5% compared to the all-time high price3 of the Exclusive Networks shares, reached on 17 May 2023.

The Proposed Transaction values 100% of Exclusive Networks’ share capital at €2.2 billion on a fully diluted basis.

The Acquisitions are conditioned upon the receipt of customary regulatory approvals, notably in connection with antitrust, foreign investment control and foreign subsidies in the European Union, the approval of an exceptional distribution in an amount of €5.29 per share by Exclusive Networks’ shareholders, and the payment of such exceptional distribution, financed in part with the proceeds of a new facility to be entered into in the context of the Proposed Transaction.

Gregory Laï, Partner at CD&R, said:

“Over the past decade, Exclusive Networks has grown to become one of the pre-eminent cybersecurity solutions businesses, building a platform to service both leading cybersecurity vendors and thousands of global partners and end-users. CD&R has a long track record in the technology sector, including highly relevant investments in IT services and solutions companies. We see an opportunity to invest in the company’s services and digital capabilities to better serve Exclusive Networks’ community of vendors. We look forward to working with the consortium, the company and its management team, to bring our expertise and partnership approach to Exclusive Networks as it looks to its next chapter of growth.”

Michail Zekkos, Partner and Co-Head of Technology, and Pierre Pozzo, Partner, at Permira, said:

“As the cybersecurity market continues to grow and evolve, Exclusive Networks is well-placed to capitalise on a number of trends including the consolidation of vendor spend and product innovation, requiring greater expertise and channel support. It has been a pleasure to work with Exclusive Networks since 2018 as the company has solidified its position as the one of the leading global cybersecurity specialists. We’d particularly like to thank Jesper and the broader Exclusive Networks team for their hard work and dedication to the company’s disruptive approach and focus on value creation for its partners. We are delighted to welcome CD&R to the consortium; our combined expertise, including CD&R’s long-track record in the IT channel ecosystem as well as Permira’s 35+ years of investing in technology, will be invaluable as we look to support the management team to continue to grow the business in a competitive market.”

Olivier Breittmayer, Founder and Non-Independent Board Member of Exclusive Networks, said:

“This is an exciting milestone in the history of Exclusive Networks. Since I founded the business in 2003, it has gone through a number of evolutions and grown to become one of the leading cybersecurity businesses globally. This reflects the significant contributions from the teams, shareholders, partners, customers and many more over the years. The consortium’s support, expertise and capital will all be critical as we look to continue our growth and capture the compelling opportunities ahead for the business.”

Business Overview and Proposed Transaction rationale

Exclusive Networks plays a critical role in the global cybersecurity value chain. The company serves as a go-to-market and technical service specialist across the globe, providing cybersecurity vendors with access to fragmented national markets, and local partners with the experience and expertise they require to serve their end-customers’ security needs. Exclusive Networks’ global footprint includes offices in over 45 countries and the ability to serve customers in over 170 countries, leveraging a portfolio of cybersecurity products and support services which range from managed security to technical accreditation and training.

Exclusive Networks has grown consistently over its 20+ year history based on secular tailwinds driving cybersecurity demand. The company’s strategy is to provide high-touch services to high-growth cybersecurity vendors through a differentiated model that combines global breadth, local depth and cybersecurity specialization; this strategy has positioned Exclusive Networks as a trusted specialist helping its partners navigate an increasingly complex world of enterprise IT security challenges and solutions.

Today, Exclusive Networks sees the opportunity to further expand its role in the global cyber ecosystem by continuing to maintain and grow the company’s vendor portfolio; by enhancing service offerings to vendors and partners alike; and by sustaining its record of historical M&A. The Proposed Transaction will allow Exclusive Networks to increase its long-term investment in these goals.

The consortium believes that private ownership will allow Exclusive Networks to leverage CD&R’s and Permira’s extensive technology expertise and commitment to investing in the success of portfolio companies. The Proposed Transaction will provide the company with additional capital and resources in order to execute its strategy and better serve its customer base.

Offer unanimously welcomed by Exclusive Networks’ Board of Directors

On July 23, 2024, the Board of Directors of Exclusive Networks unanimously welcomed the Offer without prejudice to the reasoned opinion to be issued by the Board following receipt of the fairness opinion from the independent expert.

In the context of the Offer, the Board of Directors established an ad hoc committee, comprising three independent members: Barbara Thoralfsson, Marie-Pierre de Bailliencourt and Nathalie Lomon.

Upon the recommendation of the ad hoc committee, the Board of Directors has appointed Finexsi, represented by Christophe Lambert, as an independent expert to prepare a fairness opinion on the financial terms of the Offer and has obtained a solvency opinion on the conditions of the exceptional distribution.

In addition, the Company has conducted and finalized the consultation process of the competent employee representative bodies in connection with the Proposed Transaction.

The Board of Directors has also approved the contemplated exceptional distribution of reserves and premia, in an amount of €5.29 per share. The payment of this exceptional distribution will be proposed to the shareholders’ meeting before 30 November 2025 and its payment will take place after the receipt of the regulatory approvals required in the context of the Proposed Transaction.

Key conditions and timetable of the Proposed Transaction

The Acquisitions of the shares held by Everest UK HoldCo Limited and Olivier Breittmayer are conditional on receipt of regulatory clearances, the approval of the exceptional distribution by Exclusive Networks’ shareholders, before March 22, 2025 and the payment of such exceptional distribution with the proceeds of new facility to be entered into in the context of the Proposed Transaction, no later than April 20, 2025, failing which any party may, if applicable, elect not to proceed with the Proposed Transaction. The implementation of the Acquisitions will trigger the obligation for the consortium to launch a mandatory simplified tender offer.

The Acquisitions and the subsequent filing of the Offer are expected to take place at the beginning of 2025.

Disclaimer

This press release has been prepared for information purposes only. It does not constitute an offer to purchase or a solicitation to sell Exclusive Networks shares in any country, including France. There is no certainty that the simplified tender offer mentioned above will be filed or opened. The dissemination, publication or distribution of this press release may be subject to specific regulations or restrictions in certain countries. Accordingly, persons in possession of this press release are required to inform themselves about and to comply with any local restrictions that may apply.

About CD&R

Founded in 1978, CD&R is a leading private investment firm with a strategy of generating strong investment returns by building more robust and sustainable businesses through the combination of skilled investment experience and deep operating capabilities. In partnership with the management teams of its portfolio companies, CD&R takes a long-term view of value creation and emphasizes positive stewardship and impact. The firm invests in businesses that span a broad range of industries, including industrial, healthcare, consumer, technology and financial services end markets. CD&R is privately owned by its partners and has offices in New York and London. For more information, please visit www.cdr-inc.com and follow the firm's activities through LinkedIn and @CDRBuilds on X/Twitter.

About Permira

Permira is a global investment firm that backs successful businesses with growth ambitions. Founded in 1985, the firm advises funds with total committed capital of approximately €80bn and makes long-term majority and minority investments across two core asset classes, private equity and credit.

The Permira private equity funds have make both long-term majority (Buyout) and minority (Growth Equity) investments made approximately 300 private equity investments in four key sectors: Technology, Consumer, Healthcare, and Services. The Permira funds have an extensive track record in technology investing, having invested more than $23 billion in c.80 companies across enterprise cloud adoption, cybersecurity, SaaS, fintech, digital commerce and online marketplaces.

The Permira funds have previously supported and helped scale some of the largest and fastest-growing technology businesses globally, including, Genesys, TeamViewer, Zendesk, McAfee, Mimecast, Carta, G2, Sysdig, Sonar, Mirakl and others.

Permira employs over 500 people in 16 offices across Europe, the United States and Asia. For more information, visit www.permira.com or follow us on LinkedIn.

1 Based on a total number of theoretical voting rights as of 30 June 2024 of 91,670,286.

2 Source: Bloomberg

3 Prior to initial market rumours

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240723231049/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye